
Amber D. Steele
Examiner (ID: 11314, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1639, 1654, 1676, 1658 |
| Total Applications | 1278 |
| Issued Applications | 622 |
| Pending Applications | 159 |
| Abandoned Applications | 534 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4846499
[patent_doc_number] => 20080182907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'External pharmaceutical composition containing tramadol'
[patent_app_type] => utility
[patent_app_number] => 12/010718
[patent_app_country] => US
[patent_app_date] => 2008-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2098
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20080182907.pdf
[firstpage_image] =>[orig_patent_app_number] => 12010718
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/010718 | External pharmaceutical composition containing tramadol | Jan 28, 2008 | Abandoned |
Array
(
[id] => 8738330
[patent_doc_number] => 08410100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-02
[patent_title] => 'Pteridinone derivatives as PI3-kinases inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/524791
[patent_app_country] => US
[patent_app_date] => 2008-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28434
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524791
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524791 | Pteridinone derivatives as PI3-kinases inhibitors | Jan 27, 2008 | Issued |
Array
(
[id] => 5522055
[patent_doc_number] => 20090030036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'Nuclear receptor binding agents'
[patent_app_type] => utility
[patent_app_number] => 12/010225
[patent_app_country] => US
[patent_app_date] => 2008-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 71178
[patent_no_of_claims] => 100
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20090030036.pdf
[firstpage_image] =>[orig_patent_app_number] => 12010225
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/010225 | Nuclear receptor binding agents | Jan 21, 2008 | Issued |
Array
(
[id] => 4765649
[patent_doc_number] => 20080176861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS'
[patent_app_type] => utility
[patent_app_number] => 12/017912
[patent_app_country] => US
[patent_app_date] => 2008-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21341
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176861.pdf
[firstpage_image] =>[orig_patent_app_number] => 12017912
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/017912 | SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | Jan 21, 2008 | Abandoned |
Array
(
[id] => 4960605
[patent_doc_number] => 20080275030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Methods and Compositions for the Delivery of a Therapeutic Agent'
[patent_app_type] => utility
[patent_app_number] => 12/016724
[patent_app_country] => US
[patent_app_date] => 2008-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9715
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20080275030.pdf
[firstpage_image] =>[orig_patent_app_number] => 12016724
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/016724 | Methods and Compositions for the Delivery of a Therapeutic Agent | Jan 17, 2008 | Abandoned |
Array
(
[id] => 4813926
[patent_doc_number] => 20080194557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Methods and compositions for the treatment of pain, inflammation and cancer'
[patent_app_type] => utility
[patent_app_number] => 12/015714
[patent_app_country] => US
[patent_app_date] => 2008-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20176
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194557.pdf
[firstpage_image] =>[orig_patent_app_number] => 12015714
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/015714 | Methods and compositions for the treatment of pain, inflammation and cancer | Jan 16, 2008 | Abandoned |
Array
(
[id] => 4873724
[patent_doc_number] => 20080200458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Methods and compositions for the treatment of body composition disorders'
[patent_app_type] => utility
[patent_app_number] => 12/015728
[patent_app_country] => US
[patent_app_date] => 2008-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21966
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200458.pdf
[firstpage_image] =>[orig_patent_app_number] => 12015728
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/015728 | Methods and compositions for the treatment of body composition disorders | Jan 16, 2008 | Abandoned |
Array
(
[id] => 4808201
[patent_doc_number] => 20080171779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'USE OF 5-HT6 ANTAGONISTS TO PREVENT RELAPSE INTO ADDICTION'
[patent_app_type] => utility
[patent_app_number] => 12/013898
[patent_app_country] => US
[patent_app_date] => 2008-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9067
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171779.pdf
[firstpage_image] =>[orig_patent_app_number] => 12013898
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/013898 | USE OF 5-HT6 ANTAGONISTS TO PREVENT RELAPSE INTO ADDICTION | Jan 13, 2008 | Abandoned |
Array
(
[id] => 6232111
[patent_doc_number] => 20100184862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'PROSTACYCLIN DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/520493
[patent_app_country] => US
[patent_app_date] => 2007-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11288
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184862.pdf
[firstpage_image] =>[orig_patent_app_number] => 12520493
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/520493 | PROSTACYCLIN DERIVATIVES | Dec 20, 2007 | Abandoned |
Array
(
[id] => 7682158
[patent_doc_number] => 20100022650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'Benzamide Derivatives As EP4 Receptor Agonists'
[patent_app_type] => utility
[patent_app_number] => 12/519219
[patent_app_country] => US
[patent_app_date] => 2007-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19751
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20100022650.pdf
[firstpage_image] =>[orig_patent_app_number] => 12519219
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/519219 | Benzamide derivatives as EP4 receptor agonists | Dec 11, 2007 | Issued |
Array
(
[id] => 4765639
[patent_doc_number] => 20080176851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Method for inhibiting lymphangiogenesis and inflammation'
[patent_app_type] => utility
[patent_app_number] => 11/953626
[patent_app_country] => US
[patent_app_date] => 2007-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6653
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176851.pdf
[firstpage_image] =>[orig_patent_app_number] => 11953626
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/953626 | Method for inhibiting lymphangiogenesis and inflammation | Dec 9, 2007 | Abandoned |
Array
(
[id] => 4880518
[patent_doc_number] => 20080153901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'Avermectin/benzoyl peroxide compositions for treating afflictions of the skin, e.g., rosacea'
[patent_app_type] => utility
[patent_app_number] => 12/000181
[patent_app_country] => US
[patent_app_date] => 2007-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2102
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153901.pdf
[firstpage_image] =>[orig_patent_app_number] => 12000181
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/000181 | Avermectin/benzoyl peroxide compositions for treating afflictions of the skin, e.g., rosacea | Dec 9, 2007 | Abandoned |
Array
(
[id] => 4764692
[patent_doc_number] => 20080175903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Treatment of anxiety with eszopiclone'
[patent_app_type] => utility
[patent_app_number] => 11/998839
[patent_app_country] => US
[patent_app_date] => 2007-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13187
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 57
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20080175903.pdf
[firstpage_image] =>[orig_patent_app_number] => 11998839
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/998839 | Treatment of anxiety with eszopiclone | Nov 30, 2007 | Abandoned |
Array
(
[id] => 6248862
[patent_doc_number] => 20100137270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS'
[patent_app_type] => utility
[patent_app_number] => 12/516772
[patent_app_country] => US
[patent_app_date] => 2007-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22630
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137270.pdf
[firstpage_image] =>[orig_patent_app_number] => 12516772
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/516772 | MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS | Nov 28, 2007 | Abandoned |
Array
(
[id] => 5564759
[patent_doc_number] => 20090137612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Treatment with combined use of oxypurines and ascorbate to prevent and mitigate iron-catalized oxidative damage in Alzheimer\'s disease and other neurodegenerative disorders'
[patent_app_type] => utility
[patent_app_number] => 11/986922
[patent_app_country] => US
[patent_app_date] => 2007-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5046
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137612.pdf
[firstpage_image] =>[orig_patent_app_number] => 11986922
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/986922 | Treatment with combined use of oxypurines and ascorbate to prevent and mitigate iron-catalized oxidative damage in Alzheimer's disease and other neurodegenerative disorders | Nov 26, 2007 | Abandoned |
Array
(
[id] => 6596977
[patent_doc_number] => 20100292157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'Combination Treatments for Alzheimer\'s Disease and Similar Diseases'
[patent_app_type] => utility
[patent_app_number] => 12/445164
[patent_app_country] => US
[patent_app_date] => 2007-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47843
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292157.pdf
[firstpage_image] =>[orig_patent_app_number] => 12445164
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/445164 | Combination Treatments for Alzheimer's Disease and Similar Diseases | Nov 21, 2007 | Abandoned |
Array
(
[id] => 5404606
[patent_doc_number] => 20090239920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'PHARMACEUTICAL FORMULATIONS OF AN ANHYDRATE CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL'
[patent_app_type] => utility
[patent_app_number] => 11/943143
[patent_app_country] => US
[patent_app_date] => 2007-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 36966
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239920.pdf
[firstpage_image] =>[orig_patent_app_number] => 11943143
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/943143 | PHARMACEUTICAL FORMULATIONS OF AN ANHYDRATE CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL | Nov 19, 2007 | Abandoned |
Array
(
[id] => 6026410
[patent_doc_number] => 20110053995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'BENZENESULFONANILIDE COMPOUND INHIBITORS OF UREA TRANSPORTERS'
[patent_app_type] => utility
[patent_app_number] => 12/514987
[patent_app_country] => US
[patent_app_date] => 2007-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21686
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053995.pdf
[firstpage_image] =>[orig_patent_app_number] => 12514987
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/514987 | BENZENESULFONANILIDE COMPOUND INHIBITORS OF UREA TRANSPORTERS | Nov 15, 2007 | Abandoned |
Array
(
[id] => 6594180
[patent_doc_number] => 20100048497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'INSECTICIDAL ACTIVE INGREDIENT COMBINATIONS (FORMONONETINS + INSECTICIDES)'
[patent_app_type] => utility
[patent_app_number] => 12/515954
[patent_app_country] => US
[patent_app_date] => 2007-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7933
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048497.pdf
[firstpage_image] =>[orig_patent_app_number] => 12515954
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/515954 | Insecticidal active ingredient combinations (formononetins + insecticides) | Nov 15, 2007 | Issued |
Array
(
[id] => 4887730
[patent_doc_number] => 20080262062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'METHOD OF TREATING DISEASES WITH PARP INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 11/940307
[patent_app_country] => US
[patent_app_date] => 2007-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 57487
[patent_no_of_claims] => 118
[patent_no_of_ind_claims] => 69
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262062.pdf
[firstpage_image] =>[orig_patent_app_number] => 11940307
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/940307 | METHOD OF TREATING DISEASES WITH PARP INHIBITORS | Nov 13, 2007 | Abandoned |